目的植入型心律转复除颤器(ICD)是恶性室性心律失常患者惟一有效的治疗措施。
Objective Implantable cardioverter defibrillator (ICD) is the only effective therapy in patients with life-threatening ventricular arrhythmias.
目的探索恶性心律失常行植入型心律转复除颤器(ICD)治疗的围手术期护理特点。
Objective to describe the characteristics of perioperative care of patients with malignant ventricular arrhythmia during treatment with implantable cardioverter defibrillator (ICD).
对于有室性心动过速及不服用抗心律失常药物的植入心律转复除颤器患者也需特别注意。
The same may also be true for patients with implantable cardioverter defibrillators who have a history of ventricular tachycardia and who are not taking antiarrhythmic medications.
对于一些人，比如说那些患肥厚性心肌病的人，另一个方法则是植入一个心律转复除颤器(ICD)。
Another option for some, such as those with hypertrophic cardiomyopathy, is an implantable cardioverter-defibrillator (ICD).
美国医学会杂志发布了一项研究，观察了过去4年里植入的112,000个植入型心律转复除颤器。
The study, published in the Journal of the American Medical Association, looked at 112,000 implants of cardioverter defibrillators done over the past four years.
监督这些心律转复除颤器制造商的华尔街分析员——如波士顿科学美敦力公司和圣犹达医疗用品等公司关注了这项新研究。
Wall Street analysts who monitor the makers of these implantable defibrillators - companies such as Boston Scientific, Medtronic and St. Jude Medical - paid heed to the new study.
本研究目的为检查和报告放射治疗期间永久性心脏起搏器（PM）和植入式心脏转复除颤器（ICD）功能故障的发生率与模式。
The objective of this study is to review and report the incidence and mode of PM and ICD malfunction during radiotherapy.
本研究目的为检查和报告放射治疗期间永久性心脏起搏器（PM）和植入式心脏转复除颤器（ICD）功能故障的发生率与模式。
The objective of this study is to review and report the incidence and mode of PM and ICD malfunction during radiotherapy.
应用推荐